Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PWIB123on Dec 28, 2021 7:37pm
187 Views
Post# 34266307

RE:RE:RE:RE:RE:RE:RE:RE:Drug Discovery Expert

RE:RE:RE:RE:RE:RE:RE:RE:Drug Discovery ExpertI've read a few comments on other forums about investors losing patience, getting fed up with seeing a continually dropping share price, and selling their shares.  I have no doubt some or even most of this is tax loss selling, but I'm afraid there is a building contingency of investors deciding just to move on.  I find myself struggling to hold on too, and if it weren't for the knowledge harvested here, I would've sold out and moved on already.  It's not fun being upside down.  It's not fun hearing nothing from the company.  It's not fun having less and less confidence in spite of seeing things that maybe should build confidence.  Truth is, for me, this feels more like a complete gamble compared to when I initially got in even though it's probably less.  The uncertainty level is high.  My faith is rocked.  I'm not even sure we can say the stock is so cheap that if they don't have good news soon that we still will hold the current value.  That's not proving to be true, and it has to be making others nervous too.  

Because it feels more like a gamble, I'm reluctant to buy back the shares I tax loss harvested over 31 days ago now between $3.40-$3.50.  Kind of wish I had eliminated my entire postion and bought back in now.  If I'm represenative of even a small contingency out there, Paul and THTX have their work cutout for them.  I still own a fairly significant investment with around 50,000 shares, but it feels less sure than it did before and I defnitely own too much of this one stock.  I'm a hold here now and not feeling very certain about buying back the shares I sold.  

Thankfully you all regularly provide updates on why we can feel comfortable leaning into the future with the clues you uncover.  Certainly no assurances, but some good reasons to believe.  Without those, I would be liquidating my entire position.  But still, I'm not real sure I want to allocate more of my capital to this stock at this point.
<< Previous
Bullboard Posts
Next >>